<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Enhancement of the inhibitory activity of <z:chebi fb="3" ids="16865">GABA</z:chebi> may protect ischemic neurons </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the neuroprotective effect of tiagabine, a novel <z:chebi fb="0" ids="51373">GABA agonist</z:chebi>, in reversible focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rats subjected to 2h middle cerebral artery (<z:chebi fb="70" ids="34342">MCA</z:chebi>) occlusion </plain></SENT>
<SENT sid="2" pm="."><plain>Tiagabine was given at 10, 20 and 40 mg/kg, i.p., 2 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>We found that post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> treatment with tiagabine improved neurobehavioral outcome and reduced <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> volume in a dose-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain>The data suggest that post-ischemic administration of tiagabine is neuroprotective in the focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> model </plain></SENT>
</text></document>